37 related articles for article (PubMed ID: 24464005)
1. The Potential of Integrative Cancer Treatment Using Melatonin and the Challenge of Heterogeneity in Population-Based Studies: A Case Report of Colon Cancer and a Literature Review.
Smorodin E; Chuzmarov V; Veidebaum T
Curr Oncol; 2024 Apr; 31(4):1994-2023. PubMed ID: 38668052
[TBL] [Abstract][Full Text] [Related]
2. Recurrent Glioblastoma Multiforme (grade IV - WHO 2007): a case of complete objective response - concomitant administration of Somatostatin / Octreotide, Retinoids, Vit E, Vit D3, Vit C, Melatonin, D2 R agonists (Di Bella Method.
Di Bella G; Leci J; Ricchi A; Toscano R
Neuro Endocrinol Lett; 2015; 36(2):127-32. PubMed ID: 26071580
[TBL] [Abstract][Full Text] [Related]
3. Melatonin as a treatment for gastrointestinal cancer: a review.
Xin Z; Jiang S; Jiang P; Yan X; Fan C; Di S; Wu G; Yang Y; Reiter RJ; Ji G
J Pineal Res; 2015 May; 58(4):375-87. PubMed ID: 25752643
[TBL] [Abstract][Full Text] [Related]
4. Melatonin and vitamin D: complementary therapeutic strategies for breast cancer.
Vitti-Ruela BV; Dokkedal-Silva V; Hachul H; Tufik S; Andersen ML
Support Care Cancer; 2021 Jul; 29(7):3433-3434. PubMed ID: 33677716
[No Abstract] [Full Text] [Related]
5. Nocturnal light pollution and underexposure to daytime sunlight: Complementary mechanisms of circadian disruption and related diseases.
Smolensky MH; Sackett-Lundeen LL; Portaluppi F
Chronobiol Int; 2015; 32(8):1029-48. PubMed ID: 26374931
[TBL] [Abstract][Full Text] [Related]
6. Emerging perspectives: unraveling the anticancer potential of vitamin D
Wakle KS; Mokale SN; Sakle NS
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):2877-2933. PubMed ID: 37994947
[TBL] [Abstract][Full Text] [Related]
7. Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities.
Talib WH; Alsayed AR; Abuawad A; Daoud S; Mahmod AI
Molecules; 2021 Apr; 26(9):. PubMed ID: 33923028
[TBL] [Abstract][Full Text] [Related]
8. Utilization of redox modulating small molecules that selectively act as pro-oxidants in cancer cells to open a therapeutic window for improving cancer therapy.
Petronek MS; Stolwijk JM; Murray SD; Steinbach EJ; Zakharia Y; Buettner GR; Spitz DR; Allen BG
Redox Biol; 2021 Jun; 42():101864. PubMed ID: 33485837
[TBL] [Abstract][Full Text] [Related]
9. Melatonin and urological cancers: a new therapeutic approach.
Mehrzadi MH; Hosseinzadeh A; Juybari KB; Mehrzadi S
Cancer Cell Int; 2020; 20():444. PubMed ID: 32943992
[TBL] [Abstract][Full Text] [Related]
10. Melatonin and its ubiquitous anticancer effects.
Bhattacharya S; Patel KK; Dehari D; Agrawal AK; Singh S
Mol Cell Biochem; 2019 Dec; 462(1-2):133-155. PubMed ID: 31451998
[TBL] [Abstract][Full Text] [Related]
11. Melatonin May Increase Anticancer Potential of Pleiotropic Drugs.
Bojková B; Kubatka P; Qaradakhi T; Zulli A; Kajo K
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563247
[TBL] [Abstract][Full Text] [Related]
12. Melatonin for the prevention and treatment of cancer.
Li Y; Li S; Zhou Y; Meng X; Zhang JJ; Xu DP; Li HB
Oncotarget; 2017 Jun; 8(24):39896-39921. PubMed ID: 28415828
[TBL] [Abstract][Full Text] [Related]
13. Effects of early enteral micro-feeding on neonatal serum Vitamin D levels.
Hu L; Yin X; Chu H; Zheng G
Pak J Med Sci; 2015; 31(6):1476-80. PubMed ID: 26870119
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the safety and efficacy of the first-line treatment with somatostatin combined with melatonin, retinoids, vitamin D3, and low doses of cyclophosphamide in 20 cases of breast cancer: a preliminary report.
Di Bella G; Mascia F; Ricchi A; Colori B
Neuro Endocrinol Lett; 2013; 34(7):660-8. PubMed ID: 24464005
[TBL] [Abstract][Full Text] [Related]
15. The Di Bella Method (DBM) in the treatment of prostate cancer: a preliminary retrospective study of 16 patients and a review of the literature.
Di Bella G; Mascia F; Colori B
Neuro Endocrinol Lett; 2013; 34(6):523-8. PubMed ID: 24378460
[TBL] [Abstract][Full Text] [Related]
16. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 55 cases of lymphomas.
Di Bella G; Colori B; Mascia F
Neuro Endocrinol Lett; 2012; 33(8):773-81. PubMed ID: 23391973
[TBL] [Abstract][Full Text] [Related]
17. Cyclophosphamide plus somatostatin, bromocriptin, retinoids, melatonin and ACTH in the treatment of low-grade non-Hodgkin's lymphomas at advanced stage: results of a phase II trial.
Todisco M; Casaccia P; Rossi N
Cancer Biother Radiopharm; 2001 Apr; 16(2):171-7. PubMed ID: 11385964
[TBL] [Abstract][Full Text] [Related]
18. Congenital fibrosarcoma in complete remission with Somatostatin, Bromocriptine, Retinoids, Vitamin D3, Vitamin E, Vitamin C, Melatonin, Calcium, Chondroitin sulfate associated with low doses of Cyclophosphamide in a 14-year Follow up.
Di Bella G; Toscano R; Ricchi A; Colori B
Neuro Endocrinol Lett; 2015; 36(8):725-33. PubMed ID: 26921571
[TBL] [Abstract][Full Text] [Related]
19. Melatonin and breast cancer: Evidences from preclinical and human studies.
Kubatka P; Zubor P; Busselberg D; Kwon TK; Adamek M; Petrovic D; Opatrilova R; Gazdikova K; Caprnda M; Rodrigo L; Danko J; Kruzliak P
Crit Rev Oncol Hematol; 2018 Feb; 122():133-143. PubMed ID: 29458781
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
